Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.

Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort.

Class II Cytochrome P450 Reductase Governs the Biosynthesis of Alkaloids.

Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents.

IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting.

Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.

Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation.

Simple prediction of long-term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation.

[Treatment of hepatitis C before and after liver transplantation].

Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.

Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated.

Evaluation of recombinase polymerase amplification for detection of begomoviruses by plant diagnostic clinics.

Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.

Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C.

Molecular Characterization of Acute Cellular Rejection Occurring During Intentional Immunosuppression Withdrawal in Liver Transplantation.